The combination of doxycycline with these extracts significantly improved clinical, histological, and biochemical parameters (MPO activity, MDA, GSH, NO levels, and CAT activity) compared to monotherapies, highlighting a genuine synergistic effect and offering a promising natural, integrative strategy for controlling IBD relapses. The gene discussed is CAT; the disease is inflammatory bowel disease.